← Back to Search

Orthopedic Implant

Intertrochanteric Femoral Fracture Fixation Trial

N/A
Waitlist Available
Led By Hassan R Mir, MD, MBA
Research Sponsored by Florida Orthopaedic Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months post-operatively
Awards & highlights
No Placebo-Only Group

Summary

The main goal of the study is to determine which cephalomedullary nail results in a better functional outcome for the patient with an unstable intertrochanteric hip fracture. Subjects will be randomized to fixation with either a Gamma3 cephalomedullary nail or an InterTan cephalomedullary nail. Outcomes will be reviewed over a 12 month follow-up period.

Eligible Conditions
  • Broken Hip
  • Intertrochanteric Fractures

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months post-operatively
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months post-operatively for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Hip Function
Secondary study objectives
Functional outcome
Hip Pain
Hip range of motion
+1 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Active Control
Group I: InterTan Intertrochanteric NailActive Control1 Intervention
'Surgical fixation' of intertrochanteric fracture with a cephalomedullary nail with an InterTan device (two-integrated screws)
Group II: Gamma 3 Intertrochanteric NailActive Control1 Intervention
'Surgical fixation' of intertrochanteric fracture with a cephalomedullary nail and Gamma 3 locking nail (single screw)

Find a Location

Who is running the clinical trial?

Florida Orthopaedic InstituteLead Sponsor
8 Previous Clinical Trials
380 Total Patients Enrolled
Hassan R Mir, MD, MBAPrincipal InvestigatorFlorida Orthopaedic Institute
~9 spots leftby Dec 2025